Archita Desai is a Gastroenterology physician. OpenAlex indexes 178 publications with 2,714 citations (h-index 27).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
550 University Blvd
Indianapolis, IN 462025149
Telephone
317-274-5000Provider last certified this registry record 6 Mar 2025.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20251 payment
- Sequana Medical US Inc.Program year20251 payment
- Madrigal PharmaceuticalsProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
46.4%Bile Acid17.2%Ursodiol100%Part D<11 patientsRifamycin Antibacterial8.6%Xifaxan100%Part D<11 patients+ 4 more classes in this area
Cardiovascular
36.1%Loop diuretic12.7%Furosemide100%Part D<11 patientsBeta blocker12%Carvedilol100%Part D<11 patients+ 2 more classes in this area
Nervous system
11%SSRI6.2%Trazodone Hcl100%Part D<11 patientsAntihistamine4.8%Hydroxyzine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2020–2025 per NIH RePORTER. The latest:
- Innovating acute care for liver disease through a pilot, patient-centric Hospital@Home program
Indiana University Indianapolis
FY2025$118,695R03DK139283 - The Intersection of Personalized Medicine and Implementation Science to Improve Healthcare Utilization in Cirrhosis
Indiana University Indianapolis
FY2024$180,487K23DK123408 - Innovating acute care for liver disease through a pilot, patient-centric Hospital@Home program
Indiana University Indianapolis
FY2024$129,301R03DK139283
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”